13856 research outputs found
Sort by
[[alternative]]Cell culture device and electromagnetic cell culturing system thereof
No full text[[abstract]]一種細胞培養盤包含一頂層、一擴散層以及一懸掛層。前述擴散層具有至少一流道。前述懸掛層具有複數懸掛單元。前述複數懸掛單元對應前述流道。流體經由前述流道流入前述懸掛單元並懸掛於前述懸掛單元下，使細胞在前述懸掛單元中的前述流體中進行培養。本發明之細胞培養盤可用於電磁刺激培養系統。電磁刺激培養系統結合細胞懸浮培養技術、微流體連續輸送技術、以及電磁場刺激細胞生成技術，形成一個可以連續提供培養液的穩定的細胞培養系統。本發明之細胞培養盤可以提高細胞培養的效率，以大量培養細胞並穩定細胞培養的品質
透過型電子顕微鏡のための標本調製
No full text[[abstract]]A TEM specimen kit is disclosed, which comprises: (a) a top substrate and a bottom substrate, the top and the bottom substrates being transparent and substantially parallel to each other; (b) a first spacer and a second spacer, located beneath the top substrate and sitting on the bottom substrate, the second spacer being opposite to and spaced apart from the first spacer at a distance of d; and (c) a chamber formed between the top and bottom substrate and between the first and second spacer, the chamber having two ends open to the atmosphere and characterized by having a height defined by the thickness h of the spacer, wherein the height being smaller than the diameter of a red blood cell. Also enclosed are methods for preparing a dry specimen for TEM nanoparticle characterization, and methods for analyzing TEM images of nanoparticles in a liquid sample
Specimen preparation for transmission electron microscopy
No full text[[abstract]]A TEM specimen kit is disclosed, which comprises: (a) a top substrate and a bottom substrate, the top and the bottom substrates being transparent and substantially parallel to each other; (b) a first spacer and a second spacer, located beneath the top substrate and sitting on the bottom substrate, the second spacer being opposite to and spaced apart from the first spacer at a distance of d; and (c) a chamber formed between the top and bottom substrate and between the first and second spacer, the chamber having two ends open to the atmosphere and characterized by having a height defined by the thickness h of the spacer, wherein the height being smaller than the diameter of a red blood cell. Also enclosed are methods for preparing a dry specimen for TEM nanoparticle characterization, and methods for analyzing TEM images of nanoparticles in a liquid sample
[[alternative]]Light-stimulating vibration massager
No full text[[abstract]]本發明係一種光刺激震動裝置，包括控制器、至少一發光二極體單元、震動馬達、至少一感測器、電池單元以及基板，係連結至手機，並受手機控制而運作。尤其，本發明利用控制器接收控制指令，以控制發光二極體單元的色光以及震動馬達的震動特性，進而投射色光及施加震動於皮膚的穴道位置，達到結合色光及震動的按摩功能。此外，還利用感測器感測生理信號，並由控制器接收後傳送至手機，再由手機的應用程式分析生理信號，產生並顯示相對應的生理資訊。之後，應用程式可依據生理資訊而動態改變控制指令，藉以最佳化光刺激、震動按摩功效
製備用於以體外轉譯的方法體外偵測B型肝炎病毒相關的肝癌變的試劑的用途與體外診斷套組
No full text[[abstract]]本发明揭示一种于体外侦测一分离出的核 苷酸检体具有一B型肝炎病毒表面抗原基因C端 截断突变的方法。本发明亦揭示利用上述方法的 体外诊断套
Anti-Abeta antibodies and uses thereof
No full text[[abstract]]An isolated antibody, comprising a light-chain CDR1 (L-CDR1) having the sequence of SEQ ID NO: 1, SEQ ID NO: 7, or SEQ ID NO: 14; a light-chain CDR2 (L-CDR2) having the sequence of SEQ ID NO: 2 or SEQ ID NO: 15; a light-chain CDR3 (L-CDR3) having the sequence of SEQ ID NO: 3, SEQ ID NO: 8, SEQ ID NO: 21, or SEQ ID NO: 24; a heavy-chain CDR1 (H-CDR1) having the sequence of SEQ ID NO: 4, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 16, or SEQ ID NO: 25; a heavy-chain CDR2 (H-CDR2) having the sequence of SEQ ID NO: 5, SEQ ID NO: 12, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 22, or SEQ ID NO: 26; and a heavy-chain CDR3 (H-CDR3) having the sequence of SEQ ID NO: 6, SEQ ID NO: 10, SEQ ID NO: 13, SEQ ID NO: 18, SEQ ID NO: 20, SEQ ID NO: 23, or SEQ ID NO: 27, wherein the antibody specifically binds to Aβ1-42 or an N-terminal modified form thereof
[[alternative]]Heterocyclic compounds and use thereof
No full text[[abstract]]本揭露提供一種式(I)之雜環化合物，亦揭露一種醫藥組成物包含該雜 環化合物之一者。更進一步揭露使用該雜環化合物之一者用於驅動造血幹細胞和內皮前驅細胞進入周邊循環的方法，以及用於治療組織傷害、癌症、發炎性疾病、和自體免疫疾病的方法
Heterocyclic compounds and use thereof
No full text[[abstract]]Heterocyclic compounds of Formula (I) shown herein. Also disclosed is a pharmaceutical composition containing one of the heterocyclic compounds. Further disclosed are methods of using one of the heterocyclic compounds for mobilizing hematopoietic stem cells and endothelial progenitor cells into the peripheral circulation and for treating tissue injury cancer inflammatory disease and autoimmune disease
[[alternative]]Pyrimidine compounds and use thereof
No full text[[abstract]]本揭露為一種式(I)之嘧啶化合物。還揭露了含有嘧啶化合物中之一者之醫藥組成物以及使用嘧啶化合物治療或預防化療引起之周圍神經病變之方法
Heterocyclic compounds and use thereof
No full text[[abstract]]Heterocyclic compounds of Formula (I) shown herein. Also disclosed are pharmaceutical compositions containing the heterocyclic compounds and methods of using the heterocyclic compounds to mobilize hematopoietic stem cells and endothelial progenitor cells into the peripheral circulation. Further provided are methods for treating tissue injury, cancer, inflammatory disease, and autoimmune disease with the heterocyclic compounds